Skip to Content

Who Is Eligible

The Amgen FIRST STEP™ Program is open to patients who meet the following criteria:

  • Patients who have been prescribed Neulasta® (pegfilgrastim), NEUPOGEN® (filgrastim), Nplate®* (romiplostim), XGEVA® (denosumab), or Prolia®(denosumab) treatment.
  • Currently have commercial health insurance that covers medication costs for Neulasta®, NEUPOGEN®, Nplate®, XGEVA®, or Prolia® under a medical benefit plan.
  • Not a participant in any federal, state or government-funded healthcare program, such as Medicare, Medicare Advantage, Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD) or TRICARE.
  • Not a resident, or receiving treatment where prohibited by law.

Ongoing eligibility in the Amgen FIRST STEP™ Program is contingent on submission of the required Explanation of Benefits form by the patient’s healthcare provider’s office within 45 days of use. If a patient’s co-insurance or co-payment exceeds $1000 for an applicable dose, the balance in excess of $1000 will be applied to the Amgen FIRST STEP™ Program card once the patient’s EOB form is processed by the program. Once that form has been processed, office staff simply need to swipe the card at the patient’s next visit to receive payment for amounts due to the clinic/institution. There is no retroactive coverage available under this program. Any treatment prior to the patient’s enrollment date will be considered retroactive and therefore not eligible for Amgen FIRST STEP™ benefits.


Once registered, the Amgen FIRST STEP™ Card is valid for the enrolled patient's entire course of treatment. Eligible patients may re-enroll at any time a new course of treatment with a covered Amgen product is initiated.


Patients may not seek reimbursement for value received from The Amgen FIRST STEP™ Program from any third-party payers, including a flexible spending account or healthcare savings account. If at any time patients begin receiving coverage under any federal, state or government-funded healthcare program, patients will no longer be eligible to participate in the Amgen FIRST STEP™ Program and must call 1-888-65-STEP1 (1-888-657-8371) Monday through Friday 9 am – 8 pm EST to stop participation. Restrictions may apply. Offer subject to change or discontinuation without notice. This is not health insurance.


Amgen reserves the right to modify or terminate this program, in whole or in part without notice at any time. The program is not valid where prohibited by law.